Detalhe da pesquisa
1.
Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir + Rilpivirine Treatment: Clinical Utility of a Combination of Patient, Drug Concentration, and Viral Factors Associated With Virologic Failure.
Clin Infect Dis
; 77(10): 1423-1431, 2023 11 17.
Artigo
Inglês
| MEDLINE | ID: mdl-37340869
2.
Population pharmacokinetics of cabotegravir following administration of oral tablet and long-acting intramuscular injection in adult HIV-1-infected and uninfected subjects.
Br J Clin Pharmacol
; 88(10): 4607-4622, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35695476
3.
Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis.
AIDS
; 35(9): 1333-1342, 2021 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33730748
4.
Statistics 101. A basic guide to the numbers game behind research.
Posit Aware
; 19(6): 55-8, 2008.
Artigo
Inglês
| MEDLINE | ID: mdl-19062411
5.
Risk of myocardial infarction and abacavir therapy: no increased risk across 52 GlaxoSmithKline-sponsored clinical trials in adult subjects.
J Acquir Immune Defic Syndr
; 51(1): 20-8, 2009 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-19282778
6.
Updated clinical risk factor analysis of suspected hypersensitivity reactions to abacavir.
Ann Pharmacother
; 38(12): 2171-2, 2004 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-15536137